Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse
View/ Open
Effective_use_of_mirtazapine_for_refractory_pruritus_BMJ_Palliative_Care_2014.pdf (636.9Kb)
Access Status
Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.Published Version
https://doi.org/10.1136/bmjspcare-2014-000790Metadata
Show full item recordCitation
Lee, Jonathan J, Sasha D Girouard, Valerie M Carlberg, and Arash Mostaghimi. 2014. “Effective Use of Mirtazapine for Refractory Pruritus Associated with Carcinoma En Cuirasse.” BMJ Supportive & Palliative Care 6 (1) (December 16): 119–121. doi:10.1136/bmjspcare-2014-000790.Abstract
Pruritus is a debilitating symptom that can be associated with cutaneous involvement by an underlying malignancy. We report the case of a 68-year-old woman with a history of triple- negative breast cancer who presented with extensive, localised cutaneous metastasis complicated by incapacitating, treatment- refractory pruritus localised to the anatomic regions involved by her metastatic disease. Physical examination revealed an indurated, ecchymotic, ulcerated plaque circumferentially encasing her thorax. Histopathological examination revealed substantial dermal lymphatic involvement and dilation as well as dermal collagen infiltration by tumour cells and nodules. The clinical and pathological findings were consistent with a diagnosis of carcinoma en cuirasse. Mirtazapine, a noradrenergic antidepressant with antiserotonin and antihistamine activity, was started and led to rapid, sustained relief of the patient’s pruritus. Mirtazapine may be a useful systemic agent for the palliative relief of pruritus associated with cutaneous infiltration by an underlying malignancy.Citable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:37071746
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)